163 related articles for article (PubMed ID: 31994632)
1. Intra-tumor genetic heterogeneity in Wilms tumor samples.
de Sá Pereira BM; Azevedo RM; Aguirre Neto JC; Menezes CF; Rodrigues KE; Faria PA; Camargo B; Maschietto M
Rev Assoc Med Bras (1992); 2019 Dec; 65(12):1496-1501. PubMed ID: 31994632
[TBL] [Abstract][Full Text] [Related]
2. Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials - A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meeting.
Brok J; Mavinkurve-Groothuis AMC; Drost J; Perotti D; Geller JI; Walz AL; Geoerger B; Pasqualini C; Verschuur A; Polanco A; Jones KP; van den Heuvel-Eibrink M; Graf N; Spreafico F
Eur J Cancer; 2021 Feb; 144():113-122. PubMed ID: 33341445
[TBL] [Abstract][Full Text] [Related]
3. Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications.
Cresswell GD; Apps JR; Chagtai T; Mifsud B; Bentley CC; Maschietto M; Popov SD; Weeks ME; Olsen ØE; Sebire NJ; Pritchard-Jones K; Luscombe NM; Williams RD; Mifsud W
EBioMedicine; 2016 Jul; 9():120-129. PubMed ID: 27333041
[TBL] [Abstract][Full Text] [Related]
4. The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol.
Vujanić GM; Gessler M; Ooms AHAG; Collini P; Coulomb-l'Hermine A; D'Hooghe E; de Krijger RR; Perotti D; Pritchard-Jones K; Vokuhl C; van den Heuvel-Eibrink MM; Graf N;
Nat Rev Urol; 2018 Nov; 15(11):693-701. PubMed ID: 30310143
[TBL] [Abstract][Full Text] [Related]
5. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
[TBL] [Abstract][Full Text] [Related]
6. [Wilms' tumor: reached progress and future prospects].
Tamaro P
Arch Ital Urol Androl; 1997 Sep; 69(4):227-32. PubMed ID: 9417294
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of chemotherapy based on the histological type and Wilms' tumor suppressor gene mutation in bilateral Wilms' tumor.
Shibata R; Takata A; Hashiguchi A; Umezawa A; Yamada T; Hata J
Pathol Int; 2003 Apr; 53(4):214-20. PubMed ID: 12675764
[TBL] [Abstract][Full Text] [Related]
8. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
9. Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood.
Vujanić GM; Sandstedt B; Harms D; Kelsey A; Leuschner I; de Kraker J;
Med Pediatr Oncol; 2002 Feb; 38(2):79-82. PubMed ID: 11813170
[TBL] [Abstract][Full Text] [Related]
10. Isochromosome 7q in adult Wilms' tumors: diagnostic and pathogenetic implications.
Rubin BP; Pins MR; Nielsen GP; Rosen S; Hsi BL; Fletcher JA; Renshaw AA
Am J Surg Pathol; 2000 Dec; 24(12):1663-9. PubMed ID: 11117788
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
12. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers to detect Wilms tumors in pediatric patients: where are we now?
Charlton J; Pavasovic V; Pritchard-Jones K
Future Oncol; 2015; 11(15):2221-34. PubMed ID: 26235184
[TBL] [Abstract][Full Text] [Related]
14. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK; Brown KW; Berry PJ
Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
[TBL] [Abstract][Full Text] [Related]
15. Wilms' tumor (nephroblastoma).
McLorie GA
Curr Opin Urol; 2001 Nov; 11(6):567-70. PubMed ID: 11734691
[TBL] [Abstract][Full Text] [Related]
16. WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor.
Cardoso LC; De Souza KR; De O Reis AH; Andrade RC; Britto AC; De Lima MA; Dos Santos AC; De Faria PS; Ferman S; Seuánez HN; Vargas FR
Oncol Rep; 2013 Jan; 29(1):315-20. PubMed ID: 23117548
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological and clinical correlations with genetic characteristics of Wilms' tumor: results of the Brazilian Wilms' Tumor Study Group.
Franco EL; de Camargo B; Saba L; Marques LA
Int J Cancer; 1991 Jul; 48(5):641-6. PubMed ID: 1649136
[TBL] [Abstract][Full Text] [Related]
18. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
19. Mutations of p53 in Wilms' tumors.
Takeuchi S; Bartram CR; Ludwig R; Royer-Pokora B; Schneider S; Imamura J; Koeffler HP
Mod Pathol; 1995 Jun; 8(5):483-7. PubMed ID: 7675765
[TBL] [Abstract][Full Text] [Related]
20. Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.
Chiang MR; Kuo CW; Wang WC; Hou TC; Kuo CY; Lu MY; Lai YC
Pathol Oncol Res; 2019 Jul; 25(3):1199-1206. PubMed ID: 30671724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]